Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 6, 2012, Pages 1110-1118

  Ikari, Akira ^a   Sato, Tomonari ^a   Watanabe, Ryo ^a   Yamazaki, Yasuhiro ^a   Sugatani, Junko ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

C Fos; Claudin 2; Epidermal growth factor; Lung; Matrix metalloproteinase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CLAUDIN 1; CLAUDIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PROTEIN C FOS;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION (PARAMETERS); ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; BINDING SITES; BUTADIENES; CELL LINE, TUMOR; CLAUDINS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MAP KINASE SIGNALING SYSTEM; NITRILES; PROMOTER REGIONS, GENETIC; PROTEASE INHIBITORS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; TYRPHOSTINS;

EID: 84860851588     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.04.005     Document Type: Article

References (47)

1. Rusch V., Baselga J., Cordon-Cardo C., Orazem J., Zaman M., Hoda S., McIntosh J., Kurie J., Dmitrovsky E. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res. 1993, 53:2379-2385.
2. Byrne B.J., Garst J. Epidermal growth factor receptor inhibitors and their role in non-small-cell lung cancer. Curr. Oncol. Rep. 2005, 7:241-247.
3. Umeda K., Ikenouchi J., Katahira-Tayama S., Furuse K., Sasaki H., Nakayama M., Matsui T., Tsukita S., Furuse M. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 2006, 126:741-754.
4. Matter K., Balda M.S. Signalling to and from tight junctions. Nat. Rev. Mol. Cell Biol. 2003, 4:225-236.
5. Tsukita S., Yamazaki Y., Katsuno T., Tamura A. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 2008, 27:6930-6938.
6. Powell D.W. Barrier function of epithelia. Am. J. Physiol. 1981, 241:G275-G288.
7. Matter K., Aijaz S., Tsapara A., Balda M.S. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr. Opin. Cell Biol. 2005, 17:453-458.
8. Furuse M., Sasaki H., Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J. Cell Biol. 1999, 147:891-903.
9. Itoh M., Furuse M., Morita K., Kubota K., Saitou M., Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J. Cell Biol. 1999, 147:1351-1363.
10. Wittchen E.S., Haskins J., Stevenson B.R. Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J. Biol. Chem. 1999, 274:35179-35185.
11. Piontek J., Winkler L., Wolburg H., Muller S.L., Zuleger N., Piehl C., Wiesner B., Krause G., Blasig I.E. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 2008, 22:146-158.
12. Turksen K., Troy T.C. Barriers built on claudins. J. Cell Sci. 2004, 117:2435-2447.
13. Tsukita S., Furuse M., Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2001, 2:285-293.
14. Moldvay J., Jackel M., Paska C., Soltesz I., Schaff Z., Kiss A. Distinct claudin expression profile in histologic subtypes of lung cancer. Lung Cancer 2007, 57:159-167.
15. Nichols L.S., Ashfaq R., Iacobuzio-Donahue C.A. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am. J. Clin. Pathol. 2004, 121:226-230.
16. Morin P.J. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 2005, 65:9603-9606.
17. Dhawan P., Singh A.B., Deane N.G., No Y., Shiou S.R., Schmidt C., Neff J., Washington M.K., Beauchamp R.D. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J. Clin. Invest. 2005, 115:1765-1776.
18. Coyne C.B., Gambling T.M., Boucher R.C., Carson J.L., Johnson L.G. Role of claudin interactions in airway tight junctional permeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L1166-L1178.
19. Daugherty B.L., Mateescu M., Patel A.S., Wade K., Kimura S., Gonzales L.W., Guttentag S., Ballard P.L., Koval M. Developmental regulation of claudin localization by fetal alveolar epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L1266-L1273.
20. Chao Y.C., Pan S.H., Yang S.C., Yu S.L., Che T.F., Lin C.W., Tsai M.S., Chang G.C., Wu C.H., Wu Y.Y., Lee Y.C., Hong T.M., Yang P.C. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am. J. Respir. Crit. Care Med. 2009, 179:123-133.
21. Lu Z., Ding L., Hong H., Hoggard J., Lu Q., Chen Y.H. Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway. Exp. Cell Res. 2011, 317:1935-1946.
22. Ikari A., Sato T., Takiguchi A., Atomi K., Yamazaki Y., Sugatani J. Claudin-2 knockdown decreases matrix metalloproteinase-9 activity and cell migration via suppression of nuclear Sp1 in A549 cells. Life Sci. 2011, 88:628-633.
23. Peter Y., Comellas A., Levantini E., Ingenito E.P., Shapiro S.D. Epidermal growth factor receptor and claudin-2 participate in A549 permeability and remodeling: implications for non-small cell lung cancer tumor colonization. Mol. Carcinog. 2009, 48:488-497.
24. Collins L.G., Haines C., Perkel R., Enck R.E. Lung cancer: diagnosis and management. Am. Fam. Physician 2007, 75:56-63.
25. Tsukamoto T., Nigam S.K. Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins. Am. J. Physiol. 1999, 276:F737-F750.
26. Dong J., Opresko L.K., Dempsey P.J., Lauffenburger D.A., Coffey R.J., Wiley H.S. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:6235-6240.
27. Le Gall S.M., Auger R., Dreux C., Mauduit P. Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. J. Biol. Chem. 2003, 278:45255-45268.
28. Kip1. Am. J. Physiol. Renal Physiol. 2005, 289:F72-F82.
29. Zhang Z., Yang X.Y., Cohen D.M. Hypotonicity activates transcription through ERK-dependent and -independent pathways in renal cells. Am. J. Physiol. 1998, 275:C1104-C1112.
30. Hewson C.A., Edbrooke M.R., Johnston S.L. PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J. Mol. Biol. 2004, 344:683-695.
31. Paschoud S., Bongiovanni M., Pache J.C., Citi S. Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod. Pathol. 2007, 20:947-954.
32. Dhawan P., Ahmad R., Chaturvedi R., Smith J.J., Midha R., Mittal M.K., Krishnan M., Chen X., Eschrich S., Yeatman T.J., Harris R.C., Washington M.K., Wilson K.T., Beauchamp R.D., Singh A.B. Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation. Oncogene 2011, 30:3234-3247.
33. Xin S., Huixin C., Benchang S., Aiping B., Jinhui W., Xiaoyan L., Yu W.B., Minhu C. Expression of Cdx2 and claudin-2 in the multistage tissue of gastric carcinogenesis. Oncology 2007, 73:357-365.
34. Kim T.H., Huh J.H., Lee S., Kang H., Kim G.I., An H.J. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology 2008, 53:48-55.
35. Vare P., Loikkanen I., Hirvikoski P., Vaarala M.H., Soini Y. Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma. Oncol. Rep. 2008, 19:25-31.
36. Ikari A., Takiguchi A., Atomi K., Sugatani J. Epidermal growth factor increases clathrin-dependent endocytosis and degradation of claudin-2 protein in MDCK II cells. J. Cell. Physiol. 2011, 226:2448-2456.
37. Singh A.B., Harris R.C. Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J. Biol. Chem. 2004, 279:3543-3552.
38. Guillemot L., Citi S. Cingulin regulates claudin-2 expression and cell proliferation through the small GTPase RhoA. Mol. Biol. Cell 2006, 17:3569-3577.
39. Moskaluk C.A., Zhang H., Powell S.M., Cerilli L.A., Hampton G.M., Frierson H.F. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod. Pathol. 2003, 16:913-919.
40. Guo M., Akiyama Y., House M.G., Hooker C.M., Heath E., Gabrielson E., Yang S.C., Han Y., Baylin S.B., Herman J.G., Brock M.V. Hypermethylation of the GATA genes in lung cancer. Clin. Cancer Res. 2004, 10:7917-7924.
41. Occleston N.L., Walker C. Production of multiple growth factors by a human non-small cell lung carcinoma cell line. Cancer Lett. 1993, 71:203-210.
42. Havemann K., Rotsch M., Schoneberger H.J., Erbil C., Hennig C., Jaques G. Growth regulation by insulin-like growth factors in lung cancer. J. Steroid Biochem. Mol. Biol. 1990, 37:877-882.
43. Jorgensen P.E., Nexo E., Poulsen S.S., Almendingen M., Berg T. Processing of epidermal growth factor in the rat submandibular gland by Kallikrein-like enzymes. Growth Factors 1994, 11:113-123.
44. Jahnke G.D., Chao J., Walker M.P., Diaugustine R.P. Detection of a kallikrein in the mouse lactating mammary gland: a possible processing enzyme for the epidermal growth factor precursor. Endocrinology 1994, 135:2022-2029.
45. Wu W., Samet J.M., Silbajoris R., Dailey L.A., Sheppard D., Bromberg P.A., Graves L.M. Heparin-binding epidermal growth factor cleavage mediates zinc-induced epidermal growth factor receptor phosphorylation. Am. J. Respir. Cell Mol. Biol. 2004, 30:540-547.
46. Vicent S., Lopez-Picazo J.M., Toledo G., Lozano M.D., Torre W., Garcia-Corchon C., Quero C., Soria J.C., Martin-Algarra S., Manzano R.G., Montuenga L.M. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br. J. Cancer 2004, 90:1047-1052.
47. Mattern J., Koomagi R., Volm M. Characteristics of long-term survivors of untreated lung cancer. Lung Cancer 2002, 36:277-282.